Subcutaneous use of treprostinil in pediatric pulmonary hypertension patients: A report of three cases

被引：0
|
作者：
Kavgaci, Akif [1 ]
Kula, Serdar [1 ]
Incedere, Fatma [1 ]
Terlemez, Semiha [1 ]
Tunaoglu, Fatma Sedef [1 ]
机构：
[1] Gazi Univ, Fac Med, Dept Pediat, Div Pediat Cardiol, Ankara, Turkiye
来源：
TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2023年 / 31卷 / 01期
关键词：
Pulmonary arterial hypertension; subcutaneous; treprostinil;
D O I：
10.5606/tgkdc.dergisi.2023.23748
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Treprostinil was approved by the United States Food and Drug Administration for use in the treatment of pulmonary arterial hypertension in 2002. Intravenous or subcutaneous treprostinil is used in pulmonary arterial hypertension patients in the functional classes of II-IV to alleviate exercise-related symptoms, or in cases where epoprostenol treatment should be reduced due to side effects. In this article, we describe three pediatric cases of pulmonary arterial hypertension in whom subcutaneous treprostinil was used.
引用
收藏
页码：145 / 148
页数：4
相关论文
共 50 条
  • [41] Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension
    Hubert Chen
    Erika B Rosenzweig
    S Karl Gotzkowsky
    Carl Arneson
    Andrew C Nelsen
    Robert C Bourge
    Health and Quality of Life Outcomes, 11
  • [42] Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension
    Chen, Hubert
    Rosenzweig, Erika B.
    Gotzkowsky, S. Karl
    Arneson, Carl
    Nelsen, Andrew C.
    Bourge, Robert C.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2013, 11
  • [43] Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertension
    Kamp, Jan C.
    Fuge, Jan
    Karsten, Jan F.
    Ruemke, Stefan
    Hoeper, Marius M.
    Park, Da-Hee
    Kuehn, Christian
    Olsson, Karen M.
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [44] Clinical use of extended-release oral treprostinil in the treatment of pulmonary arterial hypertension
    Pugliese, Steven C.
    Bull, Todd M.
    INTEGRATED BLOOD PRESSURE CONTROL, 2016, 9 : 1 - 7
  • [45] Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension - A double-blind, randomized, placebo-controlled trial
    Simonneau, G
    Barst, RJ
    Galie, N
    Naeije, R
    Rich, S
    Bourge, RC
    Keogh, A
    Oudiz, R
    Frost, A
    Blackburn, SD
    Crow, JW
    Rubin, LJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (06) : 800 - 804
  • [46] Safety, Tolerability and Clinical Effects of a Rapid Dose Titration of Subcutaneous Treprostinil Therapy in Pulmonary Arterial Hypertension: A Prospective Multi-Centre Trial
    Gruenig, Ekkehard
    Benjamin, Nicola
    Lange, Tobias J.
    Krueger, Ulrich
    Klose, Hans
    Neurohr, Claus
    Wilkens, Heinrike
    Halank, Michael
    Seyfarth, Hans-Juergen
    Held, Matthias
    Traube, Andrew
    Pernow, Michelle
    Grover, E. Robert
    Egenlauf, Benjamin
    Gerhardt, Felix
    Viethen, Thomas
    Rosenkranz, Stephan
    RESPIRATION, 2016, 92 (06) : 362 - 370
  • [47] Therapeutic Potential of Treprostinil Inhalation Powder for Patients with Pulmonary Arterial Hypertension: Evidence to Date
    Cassady, Steven J.
    Almario, Jose Alejandro N.
    Ramani, Gautam, V
    DRUG HEALTHCARE AND PATIENT SAFETY, 2024, 16 : 51 - 59
  • [48] Ambulatory Transition from Parenteral Prostanoid to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
    Lucas M. Kimmig
    Chuanhong Liao
    Remzi Bag
    Lung, 2020, 198 : 53 - 58
  • [49] Ambulatory Transition from Parenteral Prostanoid to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
    Kimmig, Lucas M.
    Liao, Chuanhong
    Bag, Remzi
    LUNG, 2020, 198 (01) : 53 - 58
  • [50] Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension
    Sitbon, Olivier
    Manes, Alessandra
    Jais, Xavier
    Pallazini, Massimiliano
    Humbert, Marc
    Presotto, Luis
    de Nillette, Louis
    Zaccardelli, Divid
    Davis, Gillian
    Jeff, Roger
    Simonneau, Gerald
    Galie, Naareno
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (01) : 1 - 5
12345